...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment
【24h】

First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment

机译:尽管在环境中发现阴性,但还是首次在丹麦的未使用唑的患者中从烟曲霉分离株中检测到了TR46 / Y121F / T289A和TR34 / L98H改变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Azole-resistant Aspergillus fumigatus harboring the TR34/L98H or TR46/Y121F/T289A alterations is increasingly found in Europe and Asia. Here, we present the first clinical cases of TR46/Y121/T289A and three cases of TR34/L98H outside the cystic fibrosis (CF) population in Denmark and the results of environmental surveys. Four patients (2012 to 2014) with 11 A. fumigatus and 4 Rhizomucor pusillus isolates and 239 soil samples (spring 2010 and autumn 2013, respectively) with a total of 113 A. fumigatus isolates were examined. Aspergillus isolates were screened for azole resistance using azole-containing agar. Confirmatory susceptibility testing was done using the EUCAST microbroth dilution EDEF 9.1 reference method. For relevant A. fumigatus isolates, CYP51A sequencing and microsatellite genotyping were performed. Three patients harbored TR34/L98H isolates. Two were azole naive at the time of acquisition and two were coinfected with wild-type A. fumigatus or R. pusillus isolates, complicating and delaying diagnosis. The TR46/Y121F/T289A strain was isolated in 2014 from a lung transplant patient. Genotyping indicated that susceptible and resistant Aspergillus isolates were unrelated and that no transmission between patients occurred. Azole resistance was not detected in any of the 113 soil isolates. TR 34/L98H and TR46/Y121F/T289A alterations appear to be emerging in the clinical setting in Denmark and now involve azole-naive patients. Two recent soil-sampling surveys in Denmark were unable to indicate any increased prevalence of azole-resistant A. fumigatus in the environment. These findings further support the demand for real-time susceptibility testing of all clinically relevant isolates and for studies investigating the seasonal variation and ecological niches for azole-resistant environmental A. fumigatus.
机译:在欧洲和亚洲越来越多地发现带有TR34 / L98H或TR46 / Y121F / T289A变异的耐偶氮烟曲霉。在这里,我们介绍了在丹麦的囊性纤维化(CF)人群以外的首例TR46 / Y121 / T289A临床病例和3例TR34 / L98H临床病例,以及环境调查的结果。检查了4名患者(2012年至2014年)的11株烟曲霉和4株Rhizomucor pusillus分离株以及239份土壤样本(分别为2010年春季和2013年秋季),总共有113株烟曲霉。使用含唑的琼脂筛选曲霉分离株的唑抗性。使用EUCAST微肉汤稀释EDEF 9.1参考方法进行敏感性药敏试验。对于相关的烟曲霉菌株,进行了CYP51A测序和微卫星基因分型。三例患者携带TR34 / L98H分离株。采集时有两只幼稚的幼稚动物,另外有两株与野生型烟曲霉或脓毒杆菌分离并发感染,使诊断复杂化并延误了诊断。 TR46 / Y121F / T289A菌株于2014年从一名肺移植患者中分离出来。基因分型表明易感和耐药的曲霉菌分离物无关,患者之间没有传播。在113个土壤分离物中均未检测到对唑的抗性。在丹麦的临床环境中,TR 34 / L98H和TR46 / Y121F / T289A的变化似乎正在出现,现在涉及未使用过吡咯的患者。丹麦最近进行的两次土壤采样调查无法表明环境中抗唑类烟曲霉的患病率增加。这些发现进一步支持了对所有临床相关菌株的实时药敏试验以及研究对耐唑类环境烟曲霉的季节性变化和生态位的研究的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号